Agilent reports strong growth in third quarter of 2017

Agilent Technologies has expressed satisfaction with its financial performance for the third quarter of its 2017 fiscal year, which ended on July 31st.

The company reported revenue for the quarter of $1.11 billion (861.95 million pounds), which represented a year-on-year increase of seven percent, or 7.5 percent on a core basis, after achieving sustainable above-market growth.

Agilent's life sciences and applied markets group saw strength in its chemical and energy, pharma and environmental end markets, while the CrossLab group recorded progress in services and consumables demand, and the diagnostics and genomics group saw good growth led by pharma, diagnostic and clinical markets.

The launch of several new products and the completion of the acquisition of Cobalt Light Systems were cited as key drivers of growth during the quarter.

Mike McMullen, Agilent's president and chief executive officer, said: "We had another great quarter delivering above-market revenue growth, expanding operating margins and growing our adjusted earnings per share. We saw strength across all our business groups."

For the 2017 fiscal year, Agilent expects a revenue total of between $4.435 billion and $4.455 billion.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.